CD8A and neoplasm: In another study, mice carrying B16 brain tumors were intratumorally administered DCs transduced with SFV-IL-18 particles in combination with IL-12 protein, which enhanced T helper type 1 responses from tumor specific CD4+ and CD8+ T cells and natural killers and antitumor immunity [82].